NASDAQ:CANC Tema Oncology ETF (CANC) Price, Holdings, & News → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free CANC Stock Alerts $27.44 -0.18 (-0.65%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$27.44▼$27.5450-Day Range$25.27▼$28.1252-Week Range$21.26▼$29.16Volume2,566 shsAverage Volume703 shsMarket Capitalization$18.66 millionAssets Under Management$18.77 millionDividend Yield0.51%Net Expense Ratio0.75% Stock AnalysisStock AnalysisChartDividendHoldingsRatingsSocial MediaStock AnalysisChartDividendHoldingsRatingsSocial Media Get Tema Oncology ETF alerts: Email Address About Tema Oncology ETFThe Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.Read More CANC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CANC ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive CANC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerTema Global Fund NameTema Oncology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:CANC Inception Date8/15/2023 Fund ManagerDavid Song WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionGlobal Number of Holdings48 Fund Statistics Assets Under Management$18.77 million Average Daily Volume$0.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorUS Bancorp Fund Services, LLC AdvisorTema Global Limited CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares680,000Beta1.11 Creation Unit10,000 Creation Fee$500.00 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Ad InvestorPlaceBible Shocker: Have You Seen Elon Musk’s Miracle?Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… Tema Oncology ETF ExpensesTypeCANCTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.99%0.57%0.54%0.48%0.51%Other Expenses0.00%0.72%0.54%0.34%0.58%Total Expense0.99%0.72%0.70%0.58%0.70%Fee Waiver-0.24%-0.76%-0.55%-0.22%-0.57%Net Expense0.75%0.59%0.60%0.54%0.58% Tema Oncology ETF (CANC) Holdings & ExposureTop 10 CANC HoldingsRegeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 5.48%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 5.21%Daiichi Sankyo Co LtdHolding Weight: 4.33%AstraZeneca PLCHolding Weight: 3.86%Novartis AG Registered SharesHolding Weight: 3.48%Illumina(NASDAQ:ILMN)Holding Weight: 3.24%Amgen(NASDAQ:AMGN)Holding Weight: 3.22%Revolution Medicines(NASDAQ:RVMD)Holding Weight: 3.22%Exact Sciences(NASDAQ:EXAS)Holding Weight: 2.95%argenx(NASDAQ:ARGX)Holding Weight: 2.94%CANC Sector ExposureCANC Industry ExposureFull Holdings Details Similar ETFsThemes Generative Artificial Intelligence ETFNASDAQ:WISERoundhill Video Games ETFNASDAQ:NERDProshares Equities For Rising Rates ETFNASDAQ:EQRRHorizon Kinetics SPAC Active ETFNASDAQ:SPAQRelative Sentiment Tactical Allocation ETFNASDAQ:MOOD CANC ETF - Frequently Asked Questions How have CANC shares performed in 2024? Tema Oncology ETF's stock was trading at $26.40 on January 1st, 2024. Since then, CANC stock has increased by 3.9% and is now trading at $27.4422. View the best growth stocks for 2024 here. How often does Tema Oncology ETF pay dividends? What is the dividend yield for Tema Oncology ETF? Tema Oncology ETF announced a Variable dividend on Tuesday, December 12th. Stockholders of record on Thursday, December 14th will be given a dividend of $0.1491 per share on Friday, December 15th. The ex-dividend date of this dividend is Wednesday, December 13th. Read our dividend analysis for CANC. What does CANC invest in? Tema Oncology ETF is a equity fund issued by Tema Global. CANC focuses on theme investments. The fund's investments total to approximately $18.77 million assets under management. What stocks does Tema Oncology ETF hold? CANC invests in 48 holdings. Some of the stocks in their portfolio include Regeneron Pharmaceuticals (REGN), Merck & Co., Inc. (MRK), Illumina (ILMN), Amgen (AMGN), Revolution Medicines (RVMD), Exact Sciences (EXAS), argenx (ARGX), Blueprint Medicines (BPMC), Celldex Therapeutics (CLDX) and Deciphera Pharmaceuticals (DCPH). What is the management fee for Tema Oncology ETF? Tema Oncology ETF's management fee is 0.99% and has no other recorded expenses. However, CANC has a fee waiver of -0.24% to reimburse the expenses. The net expense ratio for CANC is 0.75%. How do I buy shares of Tema Oncology ETF? Shares of CANC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CANC) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.